<ѻýҕl>No Gestational Diabetes-Cancer Link; Cholesterol and Cancer; Oncologist Saves Umpireѻýҕl> News, features, and commentary about cancer-related issues Aug 09, 2024
<ѻýҕl>IL-2 Receptor-Targeted Therapy Approved for Relapsed/Refractory CTCLѻýҕl> New iteration of denileukin diftitox led to objective responses in 36% of pretreated patients Aug 08, 2024
<ѻýҕl>Approval in Endometrial Cancer Expanded; Masks at Cancer Centers; NPR Reporter Diesѻýҕl> News, features, and commentary about cancer-related issues Aug 02, 2024
<ѻýҕl>FDA OKs Subcutaneous Daratumumab Plus VRd for Myelomaѻýҕl> Indicated for newly diagnosed patients who are eligible for stem cell transplant Jul 31, 2024
<ѻýҕl>Ancient DNA May Fuel Cancer; ASCO Appeals to Oncologists; Pesticide Cancer Riskѻýҕl> News, features, and commentary about cancer-related issues Jul 26, 2024
<ѻýҕl>These Athletes Weren't Doping. Their Genes Made It Look Like They Did.ѻýҕl> Advanced sequencing revealed genetic reasons for high hemoglobin, hematocrit levels Jul 24, 2024
<ѻýҕl>'Realistic Chance for Pregnancy' After Stem Cell Transplant, German Study Suggestsѻýҕl> 77% of pregnancies resulted in live births Jul 19, 2024
<ѻýҕl>Top Cancer Centers; Phase III Win in Prostate Cancer; Screening Recs for Anal Cancerѻýҕl> News, features, and commentary about cancer-related issues Jul 19, 2024
<ѻýҕl>Efanesoctocog Alfa Prevented Bleeding in Kids With Severe Hemophilia Aѻýҕl> No factor VIII inhibitors developed among the 74 boys included in the study Jul 17, 2024
<ѻýҕl>A First in Total Larynx Transplant; 'Sniffing' Out Lung Cancer; Gen X Cancer Tollѻýҕl> News, features, and commentary about cancer-related issues Jul 12, 2024
<ѻýҕl>Refractory Multiple Myeloma Responsive to Immunotherapy Plus Low-Dose Radiotherapyѻýҕl> A third of patients who had received multiple prior lines of therapy responded, small study shows Jul 10, 2024
<ѻýҕl>Belantamab Mafodotin: The Comeback Drug in Multiple Myelomaѻýҕl> Joseph Mikhael, MD, leads a discussion on the DREAMM-7 and DREAMM-8 trials Jul 05, 2024 video
<ѻýҕl>Unexplained CAR-T Death; Americans Spurn Sunscreen; Improving Diversity in Trialsѻýҕl> News, features, and commentary about cancer-related issues Jun 28, 2024
<ѻýҕl>Young Cervical Cancer, Leukemia Survivors at Greater Risk of Obstetric Complicationsѻýҕl> Population-based study suggests reassurance for most, high-risk strategies for some Jun 27, 2024
<ѻýҕl>Subcutaneous C5 Inhibitor Approved for PNHѻýҕl> Longer-acting crovalimab designed for more sustained effect and less treatment burden Jun 24, 2024
<ѻýҕl>EU Adds CAR-T Warning; New Blincyto Indication; Good News in Pancreatic Cancerѻýҕl> News, features, and commentary about cancer-related issues Jun 21, 2024
<ѻýҕl>Glofitamab Regimen Improves Survival in DLBCLѻýҕl> Granted accelerated approval last year, bispecific antibody passes its confirmatory test Jun 20, 2024
<ѻýҕl>Using MRD Status to Deescalate Multiple Myeloma Therapyѻýҕl> Joseph Mikhael, MD, leads a discussion on the findings of the MRD2STOP study Jun 20, 2024 video
<ѻýҕl>Multidrug Regimen Could Change Treatment Landscape for Relapsed/Refractory DLBCLѻýҕl> High-rate of durable responses with ViPOR sparks talk of supplanting CAR-T in second line Jun 19, 2024
<ѻýҕl>Novel Anti-CD38 Drug Shows Promise for Immune Thrombocytopeniaѻýҕl> "Rapid and sustained" efficacy in 95% of pretreated patients in small trial Jun 19, 2024
<ѻýҕl>Three-Drug Regimens Make Case for a Role in Untreated and Relapsed/Refractory CLLѻýҕl> Undetectable MRD rates of 90% or higher, PFS of 7 years or more Jun 17, 2024
<ѻýҕl>New Standard of Care in High-Risk Acute Promyelocytic Leukemia?ѻýҕl> All-trans retinoic acid plus arsenic trioxide and idarubicin improved EFS over standard Jun 17, 2024
<ѻýҕl>Atezolizumab Consolidation Impresses in High-Risk DLBCLѻýҕl> Will 2-year DFS of 88%, OS of 96% renew interest in checkpoint inhibitor consolidation? Jun 14, 2024
<ѻýҕl>Adding Isatuximab to Standard Backbone Prolongs PFS in Myelomaѻýҕl> Joseph Mikhael, MD, leads a roundtable discussion on two positive phase III trials from ASCO Jun 14, 2024 video
<ѻýҕl>Upping Immunotherapy Activity; A Win for Lung Screening; Looming Drug Price Break?ѻýҕl> News, features, and commentary about cancer-related issues Jun 13, 2024
<ѻýҕl>New Clues to Origin of T-Cell Lymphoma After CAR-T Therapyѻýҕl> Co-mutations, viral link, potential common susceptibility emerge from two studies Jun 12, 2024
<ѻýҕl>Brigatinib Makes Its Case for ALK-Positive ALCL in Small Studyѻýҕl> Second-gen ALK inhibitor induces high response rate, associated with impressive survival Jun 12, 2024
<ѻýҕl>Telomerase Inhibitor Approved for MDS-Related Anemiaѻýҕl> Imetelstat indicated for lower-risk myelodysplastic syndromes with transfusion-dependent anemia Jun 07, 2024
<ѻýҕl>Near-Perfect Control of Slow-Growing Lymphoma With Low-Dose Radiotherapyѻýҕl> All but four of 24 patients had complete responses to 4 Gy, local control rate of 96% at 3 years Jun 06, 2024
<ѻýҕl>'Unusual' Cancers After Pandemic; A Win in TNBC; Shortage Pauses Clinical Trialѻýҕl> News, features, and commentary about cancer-related issues Jun 06, 2024
<ѻýҕl>Star Singer's Illness; AI Imitating the Dead; Internet-Addicted Brainsѻýҕl> Health news and commentary gathered by ѻýҕl staff Jun 05, 2024
<ѻýҕl>Triplet Notches Survival Win in Heavily Pretreated DLBCLѻýҕl> Benefit with BV plus lenalidomide-rituximab seen in those who relapsed after CAR-T or transplant Jun 02, 2024
<ѻýҕl>Blenrep-Based Regimen Yields PFS Benefit in Relapsed/Refractory Myelomaѻýҕl> Second belantamab mafodotin-containing triplet to show potency in this setting Jun 02, 2024
<ѻýҕl>Kinder, Gentler Regimen for Classical Hodgkin Prevails in Randomized Trialѻýҕl> Better efficacy with brentuximab vedotin versus standard chemo, substantially less toxicity Jun 01, 2024
<ѻýҕl>Fewer Suicides in Cancer Patients; Circadian Rhythm Boost; HIV Vaccine for Cancer?ѻýҕl> News, features, and commentary about cancer-related issues May 31, 2024
<ѻýҕl>STAMP Inhibitor Tops Imatinib, Second-Gen TKIs for Newly Diagnosed CMLѻýҕl> The benefit-risk profile could change the treatment paradigm in CML, expert says May 31, 2024
<ѻýҕl>Tattoos May Be a Risk Factor for Lymphomaѻýҕl> Swedish study suggests a 21% higher risk for lymphoma in those with tattoos May 28, 2024
<ѻýҕl>Five Doctor ѻýҕl With the Most Burnout in 2024ѻýҕl> Emergency medicine and ob/gyn top the list May 24, 2024
<ѻýҕl>Doubt Cast on MGUS-Autoimmune Disease Linkѻýҕl> Population-based study fails to confirm earlier findings May 20, 2024
<ѻýҕl>What to Know About the U.K.'s Tainted Blood Scandalѻýҕl> Tens of thousands contracted HIV or hepatitis from transfusions during the 1970s and 1980s May 20, 2024